Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Miller, A. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Miller, A. E.
NEUROLOGY 1980;30:582
© 1980 American Academy of Neurology

Selective decline in cellular immune response to varicella-zoster in the elderly

Aaron E. Miller, M.D.

Department of Neurology, Albert Einstein College of Medicine, Bronx, NY.

The incidence of herpes zoster rises markedly in the aged. We evaluated the hypothesis that cellular immunity to varicella-zoster (VZ) viral antigens may be impaired in aged subjects. We found that the lymphocyte proliferation to VZ antigen was less in older asymptomatic individuals than in normal young controls. In contrast, responses to other antigens did not differ. Antibody titers to VZ were similar in both young and old subjects. Impairment of cellular immunity to VZ, on a population basis, may contribute to the increased risk of herpes zoster in the elderly.

Address correspondence and reprint requests to Dr. Miller, Department of Neurology, Albert Einstein College of Medicine, Bronx, NY 10461.

This work was supported in part by a fellowship from the National Multiple Sclerosis Society.

Presented in part at the thirty-first annual meeting of the American Academy of Neurology, Chicago, IL, April 1979.

Accepted for publication September 25, 1979.




This article has been cited by other articles:


Home page
 JAOA: Journal of the American Osteopathic AssociationHome page
M. S. Burke
Herpes Zoster Vaccine: Clinical Trial Evidence and Implications for Medical Practice
J Am Osteopath Assoc, March 1, 2007; 107(suppl_1): S14 - S18.
[Abstract] [Full Text] [PDF]

Home page
 ANN INTERN MEDHome page
G. A. Poland
The Growing Paradigm of Preventing Disease: Vaccines To Prevent Herpes Zoster and Pertussis in Adults
Ann Intern Med, October 4, 2005; 143(7): 539 - 541.
[Full Text] [PDF]

Home page
 NEJMHome page
M. N. Oxman, M.J. Levin, G.R. Johnson, K.E. Schmader, S.E. Straus, L.D. Gelb, R.D. Arbeit, M.S. Simberkoff, A.A. Gershon, L.E. Davis, et al.
A Vaccine to Prevent Herpes Zoster and Postherpetic Neuralgia in Older Adults
N. Engl. J. Med., June 2, 2005; 352(22): 2271 - 2284.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
D. H. Gilden
Varicella-Zoster Virus Vaccine -- Grown-ups Need It, Too
N. Engl. J. Med., June 2, 2005; 352(22): 2344 - 2346.
[Full Text] [PDF]

Home page
 NeurologyHome page
D. H. Gilden, R. J. Cohrs, and R. Mahalingam
VZV vasculopathy and postherpetic neuralgia: Progress and perspective on antiviral therapy
Neurology, January 11, 2005; 64(1): 21 - 25.
[Abstract] [Full Text] [PDF]

Home page
 Arch OphthalmolHome page
T. Kezuka, J.-i. Sakai, H. Minoda, M. Takeuchi, H. Keino, J. W. Streilein, and M. Usui
A Relationship Between Varicella-Zoster Virus-Specific Delayed Hypersensitivity and Varicella-Zoster Virus-Induced Anterior Uveitis
Arch Ophthalmol, September 1, 2002; 120(9): 1183 - 1188.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1980 by AAN Enterprises, Inc.